Kingsview Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,000
Closed -$67K 1057
2024
Q1
$67K Sell
25,000
-6,500
-21% -$17.4K ﹤0.01% 1001
2023
Q4
$94.2K Buy
+31,500
New +$94.2K ﹤0.01% 930